Inactive Instrument

Franchise Global Health Inc.

MERC.P

CA58937M1077

Franchise Global Health Inc. agreed to acquire Targeted Microbody Therapeutics Ug (haftungsbeschränkt).

May 15, 2022

Franchise Global Health Inc. (TSXV:FGH) agreed to acquire Targeted Microbody Therapeutics Ug (haftungsbeschränkt) on May 6, 2022.

Latest news about Franchise Global Health Inc.

Flora Growth Closes Acquisition of Franchise Global Health, Cementing Foothold in Germany and EU	28/12/22	MT
Flora Growth Corp. completed the acquisition of Franchise Global Health Inc. from a group of shareholders.	22/12/22	CI
Franchise Global Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/11/22	CI
Franchise Global Health Agrees to Be Bought by Flora Growth	24/10/22	MT
Flora Growth Corp. entered into a definitive agreement to acquire Franchise Global Health Inc. from a group of shareholders for CAD 32.2 million.	23/10/22	CI
Franchise Global Health Reports Q1 Loss, Higher Revenue	27/05/22	MT
Franchise Global to Acquire German Pharmaceutical and Medical Cannabis Products Distributor	16/05/22	MT
Franchise Global Health Inc. agreed to acquire Targeted Microbody Therapeutics Ug (haftungsbeschränkt).	15/05/22	CI
Franchise Global Health Inc. Auditor Raises 'Going Concern' Doubt	01/05/22	CI
Franchise Global Health Inc. Appoints Dany Vaiman as Chief Financial Officer	25/03/22	CI
Franchise Global Health Inc. Announces the Resignation of Hani Zabaneh as Director	25/03/22	CI
Franchise Global Health Inc. Announces Executive Changes	25/03/22	CI
Franchise Global Health Inc. Announces Management Changes	25/03/22	CI
Franchise Cannabis Corp. completed the acquisition of Mercury Acquisitions Corp. (TSXV:MERC.P).	24/03/22	CI
Franchise Global Health Inc. Auditor Raises 'Going Concern' Doubt	09/03/22	CI
Franchise Global Health Inc. acquired 100% stake in Phatebo for €15.1 million.	30/12/21	CI
Mercury Acquisitions Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22/11/21	CI
2,500,000 Common Shares of Mercury Acquisitions Corp. are subject to a Lock-Up Agreement Ending on 11-NOV-2021.	10/11/21	CI
Franchise Global Health Inc. announced that it expects to receive CAD 14.034597 million in funding	13/10/21	CI
Eve & Co Incorporated announced that it has received CAD 0.5 million in funding from Franchise Cannabis Corp.	28/09/21	CI
Mercury Acquisitions Corp. Appoints Larry W. Smith, Jakub Malczewski, and Farhan Lalani as Directors	21/09/21	CI
Mercury Acquisitions Corp. has Changed its Name to Franchise Global Health Inc	20/09/21	CI
Mercury Acquisitions Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	26/08/21	CI
Franchise Cannabis Corp. entered into a letter of intent to acquire Mercury Acquisitions Corp. (TSXV:MERC.P) from Clifford Starke, Peter Simeon, Hani Zabaneh and others for CAD 19.2 million.	23/06/21	CI
Mercury Acquisitions Corp. has completed an IPO in the amount of CAD 4 million.	11/05/21	CI

Chart Franchise Global Health Inc.

Duration

Period

More charts

Franchise Global Health Inc. is a Canada-based medical cannabis company. The Company is focused on medical cannabis operations in genetics, cultivation, and pharma distribution. It operates as a multi-national operator in the medical cannabis and pharmaceutical industries with operations, assets, strategic partnerships and investments in Germany, St. Vincent & the Grenadines, Portugal and Denmark. The Company's geographical segments include Germany and Denmark. Its subsidiaries include Harmony Health One Inc., ACA Muller, Sativa Verwaltungs GmbH, Sativa Verwaltungs GmbH and Co. KG, CBD Med Therapeutics Inc., Fayber Technologies Canada Inc., Catalunia SAS, Green CannaHealth SAS, Klokken Aarhus Inc., Rangers Pharmaceuticals A/S, 1200325 B.C. LTD., Phatebo, and FCC.

Sector

More about the company